Testing effectiveness (Phase 2)Study completedNCT02908100
What this trial is testing
The Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus
Who this might be right for
Systemic Lupus Erythematosus
Genentech, Inc. 260